Innoviva, Inc.: Piper Sandler initiates coverage with overweight rating; price target $29
INVA•Piper Sandler initiated coverage of Innoviva with an overweight rating and a $29 price target.
INVA•Piper Sandler initiated coverage of Innoviva with an overweight rating and a $29 price target.
